Study Title
A Phase 4 Open-Label Multicenter Study of PYLARIFY® PET/CT or PET/MRI in Men With Newly Diagnosed Favorable Intermediate Risk (FIR) Prostate Cancer
Study Details
Description:
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate cancer growing beyond the prostate gland in men with favorable intermediate risk prostate cancer.
Sponsor:
Lantheus Medical Imaging
Contacts:
Senior Clinical Trial Managerpyl4301studyinfo@lantheus.com
1(646) 975-2540
Government Study Link:
NCT06074510 - Click here to see study onClinicalTrials.gov